beta
VSAR
Versartis Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.
Market Cap: 77 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.versartis.com
Shares Outstanding: 35.8 Million
Float: 33.5 Million
Dividend: 0.0 (0.0%)
Beta: 2.145475
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1177 trading days
From: 2014-06-13 To: 2018-10-15
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|